(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) fell by a staggering 17.24% in 5 sessions from €5.8 to €4.80 at 20:37 EST on Thursday, after five sequential sessions in a row of losses. CAC 40 is rising 0.27% to €7,222.15, following the last session’s downward trend.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
Volatility
ABL Diagnostics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 20.83%, a negative 20.83%, and a positive 16.37%.
ABL Diagnostics’s highest amplitude of average volatility was 20.83% (last week), 20.83% (last month), and 16.37% (last quarter).
More news about ABL Diagnostics (ABLD.PA).
